FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method of producing 2,4-disubstituted furans of general formula 1, characterized by the following: the target 2,4-disubstituted furans are formed as a result of the conjugate addition of diethylamine to 1,3-disubstituted prop-2-yn-1-ones 2 during boiling in ethyl alcohol to form the corresponding enamines 3, which are further treated in situ with generated dimethylsulfonium methylide in DMSO at a room temperature.
EFFECT: creation of a simple and effective method of the synthesis of 2,4-disubstituted furans 1, based on the use of available 1,3-disubstituted prop-2-yn-1-ones, diethylamine and dimethylsulfonium methylide, allowing all stages of the process to be carried out in a one-pot mode and obtain the target products in high yields, and also vary the substituents in the 2- and 4-positions of the furan ring.
1 cl, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
2-(2-(DIALKYLAMINO POLYETHOXY))ETHYL CARBOXYLATES AND HYDROCHLORIDES THEREOF WITH ANTIARRHYTHMIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2020 |
|
RU2775616C2 |
2-SELENOXO-TETRAHYDRO-4N-IMIDAZOL-4-ONE DERIVATIVE, METHOD FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2730550C1 |
PYRAZOLE-SUBSTITUTED PYRIDINES WITH ANTICANCER ACTIVITY, THEIR USE AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2022 |
|
RU2823567C2 |
2-((4-(4-(BENZYLOXY)PYRIMIDIN-2-YL)PIPERAZIN-1-YL)METHYL)-1H-BENZO[d]IMIDAZOLE DERIVATIVES AS LOW-MOLECULAR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS | 2024 |
|
RU2838323C1 |
N-(2-(2-(DIALKYLAMINO)ETHOXY)ETHYL)CARBOXAMIDES AND HYDROCHLORIDES THEREOF, HAVING ANTIARRHYTHMIC ACTIVITY, AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2019 |
|
RU2712638C1 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
METHOD FOR PRODUCING 4-AMINO-5-FLUORO-3-HALOGEN-6- (SUBSTITUTED) PYCOLINATES | 2013 |
|
RU2632203C2 |
USE OF N-[1-ARYL-3-OXO-2-AZASPIRO[3.5]NONAN-2-YL]BENZAMIDES AS ANALGESIC MEDICINAL PRODUCTS | 2023 |
|
RU2810704C1 |
ANTITUMOR LAMELLARIN ANALOGS | 2003 |
|
RU2328500C2 |
COMPOUNDS | 2019 |
|
RU2838187C2 |
Authors
Dates
2023-12-25—Published
2023-03-22—Filed